1.The Relation between Mental Factors and Outpatient Service Utility
Jiangjiang HE ; Lingzhong XU ; Hui SUN
Chinese Mental Health Journal 2002;0(09):-
Objective:To find out the relationship between mental factors and outpatient service utility. Method: Stratum-based random sampling method was used to select samples. The sample was interviewed with both self-made questionnaire and Kessler 10 rating scale.Results:The survey covered 11652 persons aged 15 and above. The incidence within two weeks was 10.38% (10.87% in rural areas and 7.73% in urban areas), the average rate of outpatient service seeking within two weeks was 4.83% (4.97% in rural areas and 4.11% in urban areas), 63.59% of the patients selected mainly the basic health service institution when they sought outpatient service; the primary mental factor affecting utility of outpatients was the mental state (K10 score), and the OR value of the high K10 group (scored 30-50) was 2.258 (95% CI: 1.265-4.032).Conclusions:Poor mental health is associated with higher utility of out-clinic service.
2.The Efficacy and Safety of 2μm Laser Vapoenucleation of the Prostate
Jiangjiang SUN ; Long YANG ; Baolong WANG ; Liming LI ; Zhe CUI
Tianjin Medical Journal 2013;(8):769-771
Objective To evaluate the safety and effectiveness of 2μm Thulium laser vaporization enucleation (Thu-VEP) in the treatment of benign prostate hyperplasia (BPH). Methods A total of 145 patients with BPH were randomized into two groups including patients underwent ThuVEP and patients underwent standard transurethral resection of the pros-tate (TURP). The intraoperative blood loss,flushing fluid quantity,operation time,bladder irrigating time,catheterization time,the international prostate symptom score (IPSS),quality of life score (QOL),the maximum flow rate (Qmax),the post-void residual (PVR) and complications were observed in two groups. Results There were no significant differences in pa-tient age, preoperative duration, prostate weight, IPSS score,QOL score,Qmax and RUV between two groups. Patients in two groups were performed surgery successfully. The values of blood loss, bladder irrigating time and catheterization time were significantly less in ThuVEP group than those of TUEP group (P<0.05). There were no postoperative complications in pa-tients of ThuVEP group. There were 5 cases of complications in TUEP group after operation. The values of IPSS score,QOL score,Qmax and RUV were significantly different after 3-12-month follow up than those before operation(P<0.01),but no significant difference between two groups. Conclusion ThuVEP is a safe and more effective treatment than that of TURP for patients with BPH. ThuVEP can significantly improve the quality of life, and reduce complications in patients with BPH.
4.Study on the preventive use of antibiotics in removal surgery for internal fixation
Jianquan HUANG ; Jiangjiang XU ; Qiaoling YANG ; Jie GAO ; Huajun SUN
Journal of Pharmaceutical Practice 2019;37(1):74-76
Objective To investigate the preventive use of antibiotics for internal fixation as selective removal surgery during perioperative period.Methods The sex, age, routine blood examination data, preventive medications, secondary incision infection and postoperative hospital stay for the patients underwent selective removal surgery for internal fixation from July2015to June 2017were analyzed.Results The average postoperative hospitalization time for the preventive medication group (n=71) and the untreated group (n=350) were (1.80±1.24) days and (1.27±0.61) days.This difference was statistically significant (P<0.05).Conclusion Preventive antibiotics use is not related to incision infections.It is recommended to correct the current behavior of the preventive drug use.The preventive antibiotics use in selective removal surgery for internal fixation in the Department of orthopedics needs to be reduced.
5.The study and analysis of the effectiveness of "health education mobile classroom" in the outpatient department of children's hospital
Jingmin SUN ; Qunfeng LU ; Jiangjiang XU ; Hongye TIAN ; Jingjing CAO ; Hua DU ; Lijun CHEN ; Zheli ZHANG ; Youwei LI
Chinese Journal of Practical Nursing 2018;34(28):2222-2226
Objective To evaluate the effect of "health education mobile classroom " in the outpatient department of children's hospital, and to analyze the needs of the outpatient and family members on health education. Methods Through the retrospective analysis of the information of the outpatient and emergency patients in the children's specialist hospital to determine the content, the venue and the time period of the "health education mobile classroom". Selection and training the health educator to implement the health education. At the same time, push the training content through the mobile APP to the patient's family, to expand the education audience. To compare and analyze the patient satisfaction of the hospital and the satisfaction with the dimensions of the project. In the evaluation of the effect of health education and the influencing factors, the relationship between income, occupation and children is positively related, and age is negatively related to it. Results After the implement of this project, the satisfaction of the patient had increased for 3.65%(P=0.001). Overall assessment of the audience was very satisfied with (3.94 ± 0.25) points. In each dimension analysis, the satisfaction of the "training method"was the highest, at (3.94 ± 0.26) points. Satisfied with the attitude of the trainers and comprehensive ability were more than 3.80 points. Conclusions The "health education mobile classroom" can improve patient satisfaction in the outpatient department and emergency of children's specialist hospital. Audience has a certain degree of acceptance and satisfaction with this health education mode.
6.Budget Effect Analysis of Ivabradine in the Treatment of Heart Failure on Medical Insurance Fund in China
Shanlian HU ; Jiangjiang HE ; Tian SUN ; Yan YANG ; Qi KANG
China Pharmacy 2019;30(8):1094-1099
OBJECTIVE: To evaluate the effects of ivabradine in the treatment of heart failure on medical insurance fund budget in China, and to provide support evidence of related economical evaluation for medical insurance department to solve the problem of reimbursement admission of the drug in hospital outpatient department and the establishment of drug list in hospital. METHODS: Excel decision tree model was used. Pharmacoeconomic analysis was conducted based on the data reported in domestic literatures over the years. Firstly, according to the prevalence rate of heart failure in China, the number of patients with heart failure was estimated, which accorded with NYHA cardiac function class Ⅱ-Ⅳ, systolic blood pressure dysfunction and ivabradine indication. Then the cost of ivabradine was estimated. Secondly, the total number of hospitalizations and the cost of hospitalization due to heart failure were estimated. Finally, the cost of ivabredine and the cost of treatment saved by avoiding re-hospitalization due to the use of ivabredine were considered comprehensively. Static budget impact analysis was conducted to evaluate the effects of the use of ivabredine on medical insurance fund budget. RESULTS: The prevalence rate of heart failure in China was raised to 1.3% in 2013. It was estimated that the number of heart failure patients between 35-75 years old in China could be about 8.51 million and total hospitalization times was about 4.32 million per year. The economic burden of hospitalization in heart failure patients was about 168.940 billion yuan in whole country. Since 18% of patients could be avoided re-hospitalization after treatment with ivabradine, the cost of hospitalization could be saved by about 30.410 billion yuan, while the total cost of taking ivabradine was about 17.525 billion yuan. Therefore, the use of ivabradine could save the hidden medical cost budget by about 12.886 billion yuan, which had obvious cost-effectiveness. Static budget impact analysis results showed that by 2019-2020, the expected proportion of patients with heart failure covered by ivabradine would increased to 8.70%, and the total consumption sum would reach about 1.797 billion yuan. The incremental cost savings ratio (ICSR) showed that the cost of hospitalization could be saved by about 11 951 yuan for each additional case of heart failure treated with ivabradine; there could be 5 711 yuan of balance by deducting drug cost 6 240 yuan of ivabradine. CONCLUSIONS: The cost savings of hospitalization treated by ivabradine is not only enough to offset the cost of ivabradine itself, but also has a premium effect. The drug is of certain economy for the treatment of heart failure in China.